ELVN
HealthcareEnliven Therapeutics, Inc.
$27.51-1.30 (-4.51%)
Prev Close
$28.81
Open
$29.19
High
$30.06
Low
$27.49
Volume
760.1K
Market Cap
$1.79B
P/E
—
Div Yield
—
Over the past 12 months, insider activity at Enliven Therapeutics, Inc. (ELVN) has been exclusively selling, with 0 insider purchases totaling $0.00 and 64 insider sales totaling $22.11M. The most recent insider transaction was by Collins Helen Louise (officer: CHIEF MEDICAL OFFICER), who sold $1.20M worth of shares on Mar 11, 2026. Enliven Therapeutics, Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $1.79B.
Buys (12M)
0
$0.00
Sells (12M)
64
$22.11M
Net Activity
Net Seller
$22.11M
Active Insiders
6
last 12 mo
ELVN Price Chart
ELVN Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Mar 11, 2026↗ | Collins Helen Louise | officer: CHIEF MEDICAL OFFICER | Sell | 40,000 | $30.07 | $1.20M | 25,000 |
| Mar 10, 2026↗ | Hohl Benjamin | officer: CHIEF FINANCIAL OFFICER | Sell | 10,000 | $29.58 | $295.8K | 51,000 |
| Feb 19, 2026↗ | Collins Helen Louise | officer: CHIEF MEDICAL OFFICER | Sell | 45,000 | $26.17 | $1.18M | 25,000 |
| Feb 19, 2026↗ | Heyman Richard A. | director | Sell | 1,230 | $26.18 | $32.2K | 22,647 |
| Feb 17, 2026↗ | Collins Helen Louise | CHIEF MEDICAL OFFICER | Sell | 45,000 | $26.17 | $1.18M | 0 |
| Feb 17, 2026↗ | Heyman Richard A. | Director | Sell | 1,230 | $26.18 | $32.2K | 0 |
| Feb 10, 2026↗ | Lyssikatos Joseph P | officer: CHIEF SCIENTIFIC OFFICER | Sell | 5,000 | $29.04 | $145.2K | 740,188 |
| Feb 6, 2026↗ | Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Sell | 5,000 | $29.04 | $145.2K | 740,188 |
| Jan 22, 2026↗ | Heyman Richard A. | director | Sell | 1,230 | $26.75 | $32.9K | 24,595 |
| Jan 22, 2026↗ | Lyssikatos Joseph P | officer: CHIEF SCIENTIFIC OFFICER | Sell | 20,000 | $26.75 | $535.1K | 759,697 |
| Jan 20, 2026↗ | Heyman Richard A. | Director | Sell | 1,230 | $26.75 | $32.9K | 24,595 |
| Jan 20, 2026↗ | Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Sell | 20,000 | $26.75 | $535.1K | 759,697 |
| Jan 13, 2026↗ | Patel Anish | officer: CHIEF OPERATING OFFICER | Sell | 48,300 | $27.99 | $1.35M | 215,254 |
| Jan 12, 2026↗ | Heyman Richard A. | director | Sell | 13,920 | $25.02 | $348.3K | 29,392 |
| Jan 12, 2026↗ | Lyssikatos Joseph P | officer: CHIEF SCIENTIFIC OFFICER | Sell | 132,500 | $26.23 | $3.48M | 890,188 |
| Jan 9, 2026↗ | Patel Anish | CHIEF OPERATING OFFICER | Sell | 48,300 | $27.99 | $1.35M | 215,254 |
| Jan 8, 2026↗ | Heyman Richard A. | Director | Sell | 13,920 | $25.02 | $348.3K | 29,392 |
| Jan 8, 2026↗ | Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Sell | 132,500 | $26.23 | $3.48M | 890,188 |
| Dec 19, 2025↗ | Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Sell | 5,000 | $16.84 | $84.2K | 897,688 |
| Dec 8, 2025↗ | Patel Anish | CHIEF OPERATING OFFICER | Sell | 6,663 | $21.02 | $140.1K | 265,016 |
| Nov 19, 2025↗ | Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Sell | 12,500 | $22.33 | $279.2K | 903,180 |
| Nov 17, 2025↗ | Kintz Samuel | PRESIDENT AND CEO | Sell | 12,500 | $21.82 | $272.7K | 890,392 |
| Nov 7, 2025↗ | Patel Anish | CHIEF OPERATING OFFICER | Sell | 6,667 | $17.40 | $116.0K | 270,587 |
| Oct 20, 2025↗ | Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Sell | 12,500 | $22.08 | $276.0K | 915,188 |
| Oct 17, 2025↗ | Kintz Samuel | PRESIDENT AND CEO | Sell | 12,500 | $21.33 | $266.7K | 902,892 |
| Oct 7, 2025↗ | Patel Anish | CHIEF OPERATING OFFICER | Sell | 6,667 | $20.10 | $134.0K | 276,641 |
| Sep 29, 2025↗ | Hohl Benjamin | CHIEF FINANCIAL OFFICER | Sell | 3,250 | $20.40 | $66.3K | 23,000 |
| Sep 26, 2025↗ | Kintz Samuel | PRESIDENT AND CEO | Sell | 3,700 | $20.06 | $74.2K | 915,392 |
| Sep 26, 2025↗ | Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Sell | 4,000 | $20.25 | $81.0K | 927,688 |
| Sep 23, 2025↗ | Kintz Samuel | PRESIDENT AND CEO | Sell | 2,800 | $20.03 | $56.1K | 919,092 |
| Sep 23, 2025↗ | Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Sell | 1,500 | $20.03 | $30.0K | 931,688 |
| Sep 19, 2025↗ | Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Sell | 7,000 | $19.39 | $135.7K | 935,318 |
| Sep 17, 2025↗ | Kintz Samuel | PRESIDENT AND CEO | Sell | 6,000 | $19.29 | $115.7K | 922,892 |
| Sep 8, 2025↗ | Patel Anish | CHIEF OPERATING OFFICER | Sell | 6,667 | $20.24 | $135.0K | 283,308 |
| Aug 27, 2025↗ | Hohl Benjamin | CHIEF FINANCIAL OFFICER | Sell | 3,250 | $20.63 | $67.0K | 23,000 |
| Aug 19, 2025↗ | Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Sell | 12,500 | $19.86 | $248.2K | 947,688 |
| Aug 18, 2025↗ | Kintz Samuel | PRESIDENT AND CEO | Sell | 10,983 | $20.02 | $219.9K | 929,999 |
| Aug 7, 2025↗ | Patel Anish | CHIEF OPERATING OFFICER | Sell | 6,667 | $18.24 | $121.6K | 290,380 |
| Jul 28, 2025↗ | Hohl Benjamin | CHIEF FINANCIAL OFFICER | Sell | 3,250 | $20.46 | $66.5K | 23,065 |
| Jul 21, 2025↗ | Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Sell | 12,500 | $22.29 | $278.6K | 953,264 |
| Jul 17, 2025↗ | Kintz Samuel | PRESIDENT AND CEO | Sell | 12,500 | $22.52 | $281.5K | 948,742 |
| Jul 10, 2025↗ | Hohl Benjamin | CHIEF FINANCIAL OFFICER | Sell | 1,000 | $22.66 | $22.7K | 23,000 |
| Jul 7, 2025↗ | Patel Anish | CHIEF OPERATING OFFICER | Sell | 6,667 | $19.79 | $132.0K | 296,947 |
| Jun 27, 2025↗ | Hohl Benjamin | CHIEF FINANCIAL OFFICER | Sell | 3,250 | $20.91 | $68.0K | 23,198 |
| Jun 20, 2025↗ | Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Sell | 12,500 | $21.40 | $267.5K | 965,188 |
| Jun 17, 2025↗ | Kintz Samuel | PRESIDENT AND CEO | Sell | 12,500 | $22.18 | $277.3K | 954,890 |
| Jun 13, 2025↗ | Hohl Benjamin | CHIEF FINANCIAL OFFICER | Sell | 3,000 | $22.55 | $67.7K | 23,000 |
| Jun 9, 2025↗ | Patel Anish | CHIEF OPERATING OFFICER | Sell | 6,667 | $20.34 | $135.6K | 303,369 |
| Jun 3, 2025↗ | Kintz Samuel | PRESIDENT AND CEO | Sell | 7,500 | $20.05 | $150.4K | 965,392 |
| Jun 3, 2025↗ | Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Sell | 7,500 | $20.03 | $150.2K | 977,688 |
| May 27, 2025↗ | Hohl Benjamin | CHIEF FINANCIAL OFFICER | Sell | 3,250 | $16.18 | $52.6K | 23,000 |
| May 19, 2025↗ | Kintz Samuel | PRESIDENT AND CEO | Sell | 5,000 | $16.49 | $82.5K | 972,892 |
| May 19, 2025↗ | Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Sell | 5,000 | $16.31 | $81.5K | 985,188 |
| May 7, 2025↗ | Patel Anish | CHIEF OPERATING OFFICER | Sell | 6,667 | $18.39 | $122.6K | 310,470 |
| May 1, 2025↗ | Kintz Samuel | PRESIDENT AND CEO | Sell | 7,500 | $20.06 | $150.4K | 980,062 |
| May 1, 2025↗ | Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Sell | 7,500 | $20.05 | $150.4K | 992,658 |
| Apr 28, 2025↗ | Hohl Benjamin | CHIEF FINANCIAL OFFICER | Sell | 3,250 | $18.69 | $60.7K | 23,069 |
| Apr 21, 2025↗ | Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Sell | 5,000 | $16.07 | $80.4K | 998,018 |
| Apr 17, 2025↗ | Kintz Samuel | PRESIDENT AND CEO | Sell | 5,000 | $16.42 | $82.1K | 985,392 |
| Apr 7, 2025↗ | Patel Anish | CHIEF OPERATING OFFICER | Sell | 6,667 | $18.04 | $120.3K | 319,554 |
| Mar 27, 2025↗ | Hohl Benjamin | CHIEF FINANCIAL OFFICER | Sell | 3,250 | $21.33 | $69.3K | 23,000 |
| Mar 24, 2025↗ | Hohl Benjamin | CHIEF FINANCIAL OFFICER | Sell | 1,000 | $22.50 | $22.5K | 23,000 |
| Mar 19, 2025↗ | Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Sell | 12,500 | $20.61 | $257.6K | 1,002,690 |
| Mar 17, 2025↗ | Kintz Samuel | PRESIDENT AND CEO | Sell | 12,500 | $20.83 | $260.3K | 990,392 |
| Mar 7, 2025↗ | Patel Anish | CHIEF OPERATING OFFICER | Sell | 6,667 | $21.44 | $142.9K | 323,310 |
| Feb 27, 2025↗ | Hohl Benjamin | CHIEF FINANCIAL OFFICER | Sell | 3,250 | $20.41 | $66.3K | 13,000 |
| Feb 6, 2025↗ | Patel Anish | CHIEF OPERATING OFFICER | Sell | 6,667 | $21.93 | $146.2K | 329,977 |
| Feb 5, 2025↗ | Hohl Benjamin | CHIEF FINANCIAL OFFICER | Sell | 1,000 | $22.52 | $22.5K | 13,000 |
| Jan 27, 2025↗ | Hohl Benjamin | CHIEF FINANCIAL OFFICER | Sell | 3,250 | $21.59 | $70.2K | 13,000 |
| Jan 7, 2025↗ | Patel Anish | CHIEF OPERATING OFFICER | Sell | 28,367 | $24.18 | $685.9K | 336,734 |
| Dec 27, 2024↗ | Hohl Benjamin | CHIEF FINANCIAL OFFICER | Sell | 4,250 | $22.23 | $94.5K | 0 |
| Dec 13, 2024↗ | Hohl Benjamin | CHIEF FINANCIAL OFFICER | Sell | 1,000 | $25.04 | $25.0K | 13,000 |
| Nov 27, 2024↗ | Hohl Benjamin | CHIEF FINANCIAL OFFICER | Sell | 5,250 | $24.89 | $130.7K | 1,000 |
| Oct 28, 2024↗ | Hohl Benjamin | CHIEF FINANCIAL OFFICER | Sell | 6,250 | $28.56 | $178.5K | 650 |
| Oct 18, 2024↗ | Collins Helen Louise | CHIEF MEDICAL OFFICER | Sell | 816 | $30.00 | $24.5K | 0 |
| Oct 18, 2024↗ | Heyman Richard A. | Director | Sell | 1,570 | $30.00 | $47.1K | 123,673 |
| Oct 18, 2024↗ | Hohl Benjamin | CHIEF FINANCIAL OFFICER | Sell | 814 | $30.00 | $24.4K | 0 |
| Oct 18, 2024↗ | Kintz Samuel | PRESIDENT AND CEO | Sell | 924 | $30.00 | $27.7K | 1,002,890 |
| Oct 18, 2024↗ | Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Sell | 847 | $30.00 | $25.4K | 1,015,190 |
| Oct 18, 2024↗ | Patel Anish | CHIEF OPERATING OFFICER | Sell | 716 | $30.00 | $21.5K | 343,311 |
| Oct 15, 2024↗ | Heyman Richard A. | Director | Sell | 1,270 | $27.67 | $35.1K | 124,490 |
| Oct 8, 2024↗ | Ballal Rahul D. | Director | Sell | 10,420 | $28.17 | $293.6K | 22,341 |
| Oct 8, 2024↗ | Kintz Samuel | PRESIDENT AND CEO | Sell | 29,977 | $28.07 | $841.3K | 1,020,630 |
| Oct 8, 2024↗ | Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Sell | 51,145 | $28.11 | $1.44M | 1,054,010 |
| Oct 4, 2024↗ | Heyman Richard A. | Director | Sell | 2,825 | $27.51 | $77.7K | 125,760 |
| Oct 4, 2024↗ | Hohl Benjamin | CHIEF FINANCIAL OFFICER | Sell | 11,488 | $27.51 | $316.0K | 0 |
| Oct 4, 2024↗ | Kintz Samuel | PRESIDENT AND CEO | Sell | 14,936 | $27.51 | $410.9K | 1,036,520 |
| Oct 4, 2024↗ | Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Sell | 10,229 | $27.54 | $281.7K | 1,069,890 |
| Oct 1, 2024↗ | Heyman Richard A. | Director | Sell | 518 | $27.54 | $14.3K | 128,585 |
| Oct 1, 2024↗ | Hohl Benjamin | CHIEF FINANCIAL OFFICER | Sell | 521 | $27.54 | $14.3K | 0 |
| Oct 1, 2024↗ | Kintz Samuel | PRESIDENT AND CEO | Sell | 526 | $27.54 | $14.5K | 1,048,730 |
| Oct 1, 2024↗ | Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Sell | 527 | $27.54 | $14.5K | 1,077,410 |
| Sep 27, 2024↗ | Hohl Benjamin | CHIEF FINANCIAL OFFICER | Sell | 6,250 | $24.61 | $153.8K | 0 |
| Sep 16, 2024↗ | Heyman Richard A. | Director | Sell | 1,270 | $22.41 | $28.5K | 129,103 |
| Aug 29, 2024↗ | Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Sell | 12,000 | $22.49 | $269.8K | 1,077,990 |
| Aug 27, 2024↗ | Hohl Benjamin | CHIEF FINANCIAL OFFICER | Sell | 4,250 | $22.54 | $95.8K | 0 |
| Aug 26, 2024↗ | Kintz Samuel | PRESIDENT AND CEO | Sell | 12,000 | $22.89 | $274.7K | 1,049,260 |
| Aug 15, 2024↗ | Heyman Richard A. | Director | Sell | 1,270 | $23.25 | $29.5K | 130,993 |
| Jul 31, 2024↗ | Heyman Richard A. | Director | Sell | 2,351 | $27.50 | $64.7K | 131,643 |
| Jul 31, 2024↗ | Hohl Benjamin | CHIEF FINANCIAL OFFICER | Sell | 991 | $27.53 | $27.3K | 0 |
| Jul 31, 2024↗ | Kintz Samuel | PRESIDENT AND CEO | Sell | 2,270 | $27.56 | $62.6K | 1,061,260 |
| Jul 31, 2024↗ | Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Sell | 3,099 | $27.56 | $85.4K | 1,089,940 |
| Jul 29, 2024↗ | Hohl Benjamin | CHIEF FINANCIAL OFFICER | Sell | 5,250 | $26.68 | $140.1K | 61 |
| Jul 29, 2024↗ | Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Sell | 12,000 | $26.70 | $320.4K | 1,093,240 |
| Jul 25, 2024↗ | Kintz Samuel | PRESIDENT AND CEO | Sell | 12,000 | $24.92 | $299.1K | 1,071,730 |
| Jul 15, 2024↗ | Heyman Richard A. | Director | Sell | 1,270 | $24.80 | $31.5K | 133,345 |
| Jul 12, 2024↗ | Hohl Benjamin | CHIEF FINANCIAL OFFICER | Sell | 3,000 | $25.07 | $75.2K | 0 |
| Jul 12, 2024↗ | Patel Anish | CHIEF OPERATING OFFICER | Sell | 50,000 | $25.06 | $1.25M | 376,552 |
| Jul 1, 2024↗ | Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Sell | 12,000 | $22.89 | $274.7K | 1,105,040 |
| Jun 27, 2024↗ | Hohl Benjamin | CHIEF FINANCIAL OFFICER | Sell | 4,250 | $22.57 | $95.9K | 2,970 |
| Jun 25, 2024↗ | Kintz Samuel | PRESIDENT AND CEO | Sell | 12,000 | $21.66 | $259.9K | 1,076,100 |
| Jun 17, 2024↗ | Heyman Richard A. | Director | Sell | 1,270 | $21.48 | $27.3K | 134,615 |
| Jun 6, 2024↗ | Patel Anish | CHIEF OPERATING OFFICER | Sell | 1,133 | $20.06 | $22.7K | 0 |
| May 29, 2024↗ | Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Sell | 12,000 | $21.73 | $260.8K | 2,123 |
| May 28, 2024↗ | Hohl Benjamin | CHIEF FINANCIAL OFFICER | Sell | 4,250 | $23.18 | $98.5K | 2,344 |
| May 28, 2024↗ | Kintz Samuel | PRESIDENT AND CEO | Sell | 12,000 | $23.18 | $278.2K | 5,319 |
| May 16, 2024↗ | Gupta Rishi | Director | Sell | 1,033,300 | $22.14 | $22.88M | 7,663,350 |
| May 16, 2024↗ | Heyman Richard A. | Director | Sell | 1,270 | $23.74 | $30.1K | 135,885 |
| May 14, 2024↗ | Patel Anish | CHIEF OPERATING OFFICER | Sell | 1,107 | $25.00 | $27.7K | 0 |
| May 9, 2024↗ | Patel Anish | CHIEF OPERATING OFFICER | Sell | 260 | $25.06 | $6.5K | 0 |
| May 6, 2024↗ | Patel Anish | CHIEF OPERATING OFFICER | Sell | 4,875 | $22.72 | $110.8K | 0 |
| May 3, 2024↗ | Hohl Benjamin | CHIEF FINANCIAL OFFICER | Sell | 1,000 | $22.50 | $22.5K | 0 |
| Apr 29, 2024↗ | Hohl Benjamin | CHIEF FINANCIAL OFFICER | Sell | 3,250 | $16.97 | $55.2K | 0 |
| Apr 29, 2024↗ | Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Sell | 12,000 | $17.92 | $215.0K | 1,013 |
| Apr 25, 2024↗ | Kintz Samuel | PRESIDENT AND CEO | Sell | 12,000 | $16.89 | $202.7K | 0 |
| Apr 11, 2024↗ | Collins Helen Louise | CHIEF MEDICAL OFFICER | Sell | 20,000 | $25.07 | $501.5K | 0 |
| Apr 11, 2024↗ | Heyman Richard A. | Director | Sell | 6,964 | $24.11 | $167.9K | 137,235 |
| Apr 11, 2024↗ | Hohl Benjamin | CHIEF FINANCIAL OFFICER | Sell | 14,000 | $24.72 | $346.1K | 10,223 |
| Apr 11, 2024↗ | Kintz Samuel | PRESIDENT AND CEO | Sell | 47,709 | $25.04 | $1.19M | 0 |
| Apr 11, 2024↗ | Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Sell | 30,000 | $25.04 | $751.3K | 0 |
| Apr 11, 2024↗ | Patel Anish | CHIEF OPERATING OFFICER | Sell | 17,500 | $25.03 | $438.1K | 0 |
| Apr 10, 2024↗ | Ballal Rahul D. | Director | Sell | 67,000 | $23.36 | $1.56M | 45,441 |
| Apr 8, 2024↗ | Patel Anish | CHIEF OPERATING OFFICER | Sell | 4,875 | $18.60 | $90.7K | 3,141 |
| Apr 4, 2024↗ | Ballal Rahul D. | Director | Sell | 3,485 | $19.15 | $66.7K | 22,341 |
| Apr 1, 2024↗ | Ballal Rahul D. | Director | Sell | 3,237 | $19.08 | $61.8K | 22,341 |
| Apr 1, 2024↗ | Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Sell | 12,000 | $18.60 | $223.1K | 9,648 |
| Mar 27, 2024↗ | Hohl Benjamin | CHIEF FINANCIAL OFFICER | Sell | 3,250 | $18.25 | $59.3K | 182 |
| Mar 25, 2024↗ | Kintz Samuel | PRESIDENT AND CEO | Sell | 12,000 | $17.56 | $210.7K | 4,671 |
| Mar 20, 2024↗ | Ballal Rahul D. | Director | Sell | 13,278 | $19.16 | $254.5K | 22,341 |
| Mar 19, 2024↗ | Heyman Richard A. | Director | Sell | 1,270 | $14.50 | $18.4K | 143,470 |
| Mar 6, 2024↗ | Patel Anish | CHIEF OPERATING OFFICER | Sell | 4,875 | $15.64 | $76.2K | 7,472 |
| Feb 29, 2024↗ | Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Sell | 12,000 | $16.42 | $197.0K | 1,805 |
| Feb 27, 2024↗ | Hohl Benjamin | CHIEF FINANCIAL OFFICER | Sell | 3,250 | $16.97 | $55.2K | 0 |
| Feb 26, 2024↗ | Kintz Samuel | PRESIDENT AND CEO | Sell | 12,000 | $16.89 | $202.7K | 4,376 |
| Feb 15, 2024↗ | Heyman Richard A. | Director | Sell | 1,270 | $17.42 | $22.1K | 144,740 |
| Feb 6, 2024↗ | Patel Anish | CHIEF OPERATING OFFICER | Sell | 4,875 | $15.11 | $73.7K | 12,347 |
| Jan 30, 2024↗ | Heyman Richard A. | Director | Sell | 1,270 | $16.41 | $20.8K | 146,010 |
| Jan 29, 2024↗ | Hohl Benjamin | CHIEF FINANCIAL OFFICER | Sell | 3,250 | $15.81 | $51.4K | 0 |
| Jan 29, 2024↗ | Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Sell | 12,000 | $15.85 | $190.3K | 0 |
| Jan 25, 2024↗ | Kintz Samuel | President and CEO | Sell | 12,000 | $15.69 | $188.2K | 9,458 |
| Jan 22, 2024↗ | Patel Anish | Chief Operating Officer | Sell | 4,875 | $15.13 | $73.8K | 17,222 |
| Dec 29, 2023↗ | Lyssikatos Joseph P | Chief Scientific Officer | Sell | 12,000 | $14.28 | $171.4K | 2,849 |
| Dec 28, 2023↗ | Hohl Benjamin | Chief Financial Officer | Sell | 11,870 | $15.02 | $178.3K | 0 |
| Dec 28, 2023↗ | Patel Anish | Chief Operating Officer | Sell | 13,540 | $15.02 | $203.3K | 33,117 |
| Dec 26, 2023↗ | Kintz Samuel | President and CEO | Sell | 12,000 | $14.64 | $175.7K | 0 |
| Dec 22, 2023↗ | Hohl Benjamin | Chief Financial Officer | Sell | 1,130 | $15.07 | $17.0K | 0 |
| Dec 22, 2023↗ | Patel Anish | Chief Operating Officer | Sell | 1,085 | $15.03 | $16.3K | 35,739 |
| Dec 21, 2023↗ | Heyman Richard A. | Director | Sell | 216 | $13.00 | $2.8K | 147,448 |
| Dec 21, 2023↗ | Kintz Samuel | President and CEO | Sell | 8,195 | $13.05 | $106.9K | 0 |
| Dec 21, 2023↗ | Lyssikatos Joseph P | Chief Scientific Officer | Sell | 6,566 | $13.07 | $85.8K | 0 |
| Dec 20, 2023↗ | Kintz Samuel | President and CEO | Sell | 7,779 | $13.01 | $101.2K | 0 |
| Dec 19, 2023↗ | Heyman Richard A. | Director | Sell | 4,280 | $13.02 | $55.7K | 149,565 |
| Dec 19, 2023↗ | Lyssikatos Joseph P | Chief Scientific Officer | Sell | 8,888 | $13.01 | $115.6K | 0 |
| Nov 3, 2023↗ | Kintz Samuel | President and CEO | Sell | 8,026 | $13.08 | $105.0K | 0 |
| Nov 3, 2023↗ | Lyssikatos Joseph P | Chief Scientific Officer | Sell | 8,546 | $13.08 | $111.8K | 0 |
| Sep 29, 2023↗ | Lyssikatos Joseph P | Chief Scientific Officer | Sell | 12,000 | $13.62 | $163.5K | 0 |
| Sep 25, 2023↗ | Kintz Samuel | President and CEO | Sell | 12,000 | $13.81 | $165.7K | 0 |
| Feb 22, 2023↗ | Ballal Rahul D. | Chief Executive Officer | Sell | 32,861 | $4.66 | $153.1K | 87,835 |
| Feb 22, 2023↗ | GRAY MICHAEL | CFO & COO | Sell | 9,856 | $4.67 | $46.0K | 27,610 |
| Jan 30, 2023↗ | Ballal Rahul D. | Chief Executive Officer | Sell | 11,313 | $3.91 | $44.2K | 120,696 |
| Jan 30, 2023↗ | GRAY MICHAEL | CFO & COO | Sell | 3,596 | $3.92 | $14.1K | 37,466 |
| Jan 3, 2023↗ | Leonard Braden Michael | 10% Owner | Sell | 1,250,000 | $4.00 | $5.00M | 1,767,770 |
| Dec 30, 2022↗ | Leonard Braden Michael | 10% Owner | Sell | 20,000 | $4.04 | $80.8K | 230,000 |
| Dec 28, 2022↗ | Leonard Braden Michael | 10% Owner | Sell | 20,000 | $4.04 | $80.8K | 269,843 |
| Dec 22, 2022↗ | Leonard Braden Michael | 10% Owner | Sell | 50,000 | $4.06 | $203.0K | 318,922 |
| Jun 16, 2022↗ | Leonard Braden Michael | 10% Owner | Buy | 83,199 | $1.11 | $92.2K | 3,017,770 |
| Jun 3, 2022↗ | Leonard Braden Michael | 10% Owner | Buy | 33,430 | $1.14 | $38.0K | 2,934,580 |
| May 16, 2022↗ | Leonard Braden Michael | 10% Owner | Buy | 41,145 | $1.23 | $50.4K | 2,901,140 |
| Apr 21, 2022↗ | Leonard Braden Michael | 10% Owner | Buy | 560,000 | $1.40 | $783.8K | 2,860,000 |
| Feb 18, 2022↗ | MOTT DAVID M | Director | Buy | 151,472 | $1.45 | $219.7K | 229,224 |
| Feb 15, 2022↗ | MOTT DAVID M | Director | Buy | 45,926 | $1.19 | $54.7K | 77,752 |
| Feb 10, 2022↗ | MOTT DAVID M | Director | Buy | 31,826 | $1.23 | $39.2K | 31,826 |
| Jul 16, 2021↗ | Bonita David P | Director | Buy | 1,666,666 | $6.00 | $10.00M | 1,666,670 |
| Jul 16, 2021↗ | Chin Mark | Director | Buy | 1,333,333 | $6.00 | $8.00M | 2,344,070 |
ELVN Insider Buying Activity
The following table shows recent insider purchases of Enliven Therapeutics, Inc. (ELVN) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Jun 16, 2022↗ | Leonard Braden Michael | 10% Owner | Buy | 83,199 | $1.11 | $92.2K | 3,017,770 |
| Jun 3, 2022↗ | Leonard Braden Michael | 10% Owner | Buy | 33,430 | $1.14 | $38.0K | 2,934,580 |
| May 16, 2022↗ | Leonard Braden Michael | 10% Owner | Buy | 41,145 | $1.23 | $50.4K | 2,901,140 |
| Apr 21, 2022↗ | Leonard Braden Michael | 10% Owner | Buy | 560,000 | $1.40 | $783.8K | 2,860,000 |
| Feb 18, 2022↗ | MOTT DAVID M | Director | Buy | 151,472 | $1.45 | $219.7K | 229,224 |
| Feb 15, 2022↗ | MOTT DAVID M | Director | Buy | 45,926 | $1.19 | $54.7K | 77,752 |
| Feb 10, 2022↗ | MOTT DAVID M | Director | Buy | 31,826 | $1.23 | $39.2K | 31,826 |
| Jul 16, 2021↗ | Bonita David P | Director | Buy | 1,666,666 | $6.00 | $10.00M | 1,666,670 |
| Jul 16, 2021↗ | Chin Mark | Director | Buy | 1,333,333 | $6.00 | $8.00M | 2,344,070 |
ELVN Insider Selling Activity
The following table shows recent insider sales of Enliven Therapeutics, Inc. (ELVN) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Mar 11, 2026↗ | Collins Helen Louise | officer: CHIEF MEDICAL OFFICER | Sell | 40,000 | $30.07 | $1.20M | 25,000 |
| Mar 10, 2026↗ | Hohl Benjamin | officer: CHIEF FINANCIAL OFFICER | Sell | 10,000 | $29.58 | $295.8K | 51,000 |
| Feb 19, 2026↗ | Collins Helen Louise | officer: CHIEF MEDICAL OFFICER | Sell | 45,000 | $26.17 | $1.18M | 25,000 |
| Feb 19, 2026↗ | Heyman Richard A. | director | Sell | 1,230 | $26.18 | $32.2K | 22,647 |
| Feb 17, 2026↗ | Collins Helen Louise | CHIEF MEDICAL OFFICER | Sell | 45,000 | $26.17 | $1.18M | 0 |
| Feb 17, 2026↗ | Heyman Richard A. | Director | Sell | 1,230 | $26.18 | $32.2K | 0 |
| Feb 10, 2026↗ | Lyssikatos Joseph P | officer: CHIEF SCIENTIFIC OFFICER | Sell | 5,000 | $29.04 | $145.2K | 740,188 |
| Feb 6, 2026↗ | Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Sell | 5,000 | $29.04 | $145.2K | 740,188 |
| Jan 22, 2026↗ | Heyman Richard A. | director | Sell | 1,230 | $26.75 | $32.9K | 24,595 |
| Jan 22, 2026↗ | Lyssikatos Joseph P | officer: CHIEF SCIENTIFIC OFFICER | Sell | 20,000 | $26.75 | $535.1K | 759,697 |
| Jan 20, 2026↗ | Heyman Richard A. | Director | Sell | 1,230 | $26.75 | $32.9K | 24,595 |
| Jan 20, 2026↗ | Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Sell | 20,000 | $26.75 | $535.1K | 759,697 |
| Jan 13, 2026↗ | Patel Anish | officer: CHIEF OPERATING OFFICER | Sell | 48,300 | $27.99 | $1.35M | 215,254 |
| Jan 12, 2026↗ | Heyman Richard A. | director | Sell | 13,920 | $25.02 | $348.3K | 29,392 |
| Jan 12, 2026↗ | Lyssikatos Joseph P | officer: CHIEF SCIENTIFIC OFFICER | Sell | 132,500 | $26.23 | $3.48M | 890,188 |
| Jan 9, 2026↗ | Patel Anish | CHIEF OPERATING OFFICER | Sell | 48,300 | $27.99 | $1.35M | 215,254 |
| Jan 8, 2026↗ | Heyman Richard A. | Director | Sell | 13,920 | $25.02 | $348.3K | 29,392 |
| Jan 8, 2026↗ | Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Sell | 132,500 | $26.23 | $3.48M | 890,188 |
| Dec 19, 2025↗ | Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Sell | 5,000 | $16.84 | $84.2K | 897,688 |
| Dec 8, 2025↗ | Patel Anish | CHIEF OPERATING OFFICER | Sell | 6,663 | $21.02 | $140.1K | 265,016 |
| Nov 19, 2025↗ | Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Sell | 12,500 | $22.33 | $279.2K | 903,180 |
| Nov 17, 2025↗ | Kintz Samuel | PRESIDENT AND CEO | Sell | 12,500 | $21.82 | $272.7K | 890,392 |
| Nov 7, 2025↗ | Patel Anish | CHIEF OPERATING OFFICER | Sell | 6,667 | $17.40 | $116.0K | 270,587 |
| Oct 20, 2025↗ | Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Sell | 12,500 | $22.08 | $276.0K | 915,188 |
| Oct 17, 2025↗ | Kintz Samuel | PRESIDENT AND CEO | Sell | 12,500 | $21.33 | $266.7K | 902,892 |
| Oct 7, 2025↗ | Patel Anish | CHIEF OPERATING OFFICER | Sell | 6,667 | $20.10 | $134.0K | 276,641 |
| Sep 29, 2025↗ | Hohl Benjamin | CHIEF FINANCIAL OFFICER | Sell | 3,250 | $20.40 | $66.3K | 23,000 |
| Sep 26, 2025↗ | Kintz Samuel | PRESIDENT AND CEO | Sell | 3,700 | $20.06 | $74.2K | 915,392 |
| Sep 26, 2025↗ | Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Sell | 4,000 | $20.25 | $81.0K | 927,688 |
| Sep 23, 2025↗ | Kintz Samuel | PRESIDENT AND CEO | Sell | 2,800 | $20.03 | $56.1K | 919,092 |
| Sep 23, 2025↗ | Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Sell | 1,500 | $20.03 | $30.0K | 931,688 |
| Sep 19, 2025↗ | Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Sell | 7,000 | $19.39 | $135.7K | 935,318 |
| Sep 17, 2025↗ | Kintz Samuel | PRESIDENT AND CEO | Sell | 6,000 | $19.29 | $115.7K | 922,892 |
| Sep 8, 2025↗ | Patel Anish | CHIEF OPERATING OFFICER | Sell | 6,667 | $20.24 | $135.0K | 283,308 |
| Aug 27, 2025↗ | Hohl Benjamin | CHIEF FINANCIAL OFFICER | Sell | 3,250 | $20.63 | $67.0K | 23,000 |
| Aug 19, 2025↗ | Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Sell | 12,500 | $19.86 | $248.2K | 947,688 |
| Aug 18, 2025↗ | Kintz Samuel | PRESIDENT AND CEO | Sell | 10,983 | $20.02 | $219.9K | 929,999 |
| Aug 7, 2025↗ | Patel Anish | CHIEF OPERATING OFFICER | Sell | 6,667 | $18.24 | $121.6K | 290,380 |
| Jul 28, 2025↗ | Hohl Benjamin | CHIEF FINANCIAL OFFICER | Sell | 3,250 | $20.46 | $66.5K | 23,065 |
| Jul 21, 2025↗ | Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Sell | 12,500 | $22.29 | $278.6K | 953,264 |
| Jul 17, 2025↗ | Kintz Samuel | PRESIDENT AND CEO | Sell | 12,500 | $22.52 | $281.5K | 948,742 |
| Jul 10, 2025↗ | Hohl Benjamin | CHIEF FINANCIAL OFFICER | Sell | 1,000 | $22.66 | $22.7K | 23,000 |
| Jul 7, 2025↗ | Patel Anish | CHIEF OPERATING OFFICER | Sell | 6,667 | $19.79 | $132.0K | 296,947 |
| Jun 27, 2025↗ | Hohl Benjamin | CHIEF FINANCIAL OFFICER | Sell | 3,250 | $20.91 | $68.0K | 23,198 |
| Jun 20, 2025↗ | Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Sell | 12,500 | $21.40 | $267.5K | 965,188 |
| Jun 17, 2025↗ | Kintz Samuel | PRESIDENT AND CEO | Sell | 12,500 | $22.18 | $277.3K | 954,890 |
| Jun 13, 2025↗ | Hohl Benjamin | CHIEF FINANCIAL OFFICER | Sell | 3,000 | $22.55 | $67.7K | 23,000 |
| Jun 9, 2025↗ | Patel Anish | CHIEF OPERATING OFFICER | Sell | 6,667 | $20.34 | $135.6K | 303,369 |
| Jun 3, 2025↗ | Kintz Samuel | PRESIDENT AND CEO | Sell | 7,500 | $20.05 | $150.4K | 965,392 |
| Jun 3, 2025↗ | Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Sell | 7,500 | $20.03 | $150.2K | 977,688 |
| May 27, 2025↗ | Hohl Benjamin | CHIEF FINANCIAL OFFICER | Sell | 3,250 | $16.18 | $52.6K | 23,000 |
| May 19, 2025↗ | Kintz Samuel | PRESIDENT AND CEO | Sell | 5,000 | $16.49 | $82.5K | 972,892 |
| May 19, 2025↗ | Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Sell | 5,000 | $16.31 | $81.5K | 985,188 |
| May 7, 2025↗ | Patel Anish | CHIEF OPERATING OFFICER | Sell | 6,667 | $18.39 | $122.6K | 310,470 |
| May 1, 2025↗ | Kintz Samuel | PRESIDENT AND CEO | Sell | 7,500 | $20.06 | $150.4K | 980,062 |
| May 1, 2025↗ | Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Sell | 7,500 | $20.05 | $150.4K | 992,658 |
| Apr 28, 2025↗ | Hohl Benjamin | CHIEF FINANCIAL OFFICER | Sell | 3,250 | $18.69 | $60.7K | 23,069 |
| Apr 21, 2025↗ | Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Sell | 5,000 | $16.07 | $80.4K | 998,018 |
| Apr 17, 2025↗ | Kintz Samuel | PRESIDENT AND CEO | Sell | 5,000 | $16.42 | $82.1K | 985,392 |
| Apr 7, 2025↗ | Patel Anish | CHIEF OPERATING OFFICER | Sell | 6,667 | $18.04 | $120.3K | 319,554 |
| Mar 27, 2025↗ | Hohl Benjamin | CHIEF FINANCIAL OFFICER | Sell | 3,250 | $21.33 | $69.3K | 23,000 |
| Mar 24, 2025↗ | Hohl Benjamin | CHIEF FINANCIAL OFFICER | Sell | 1,000 | $22.50 | $22.5K | 23,000 |
| Mar 19, 2025↗ | Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Sell | 12,500 | $20.61 | $257.6K | 1,002,690 |
| Mar 17, 2025↗ | Kintz Samuel | PRESIDENT AND CEO | Sell | 12,500 | $20.83 | $260.3K | 990,392 |
| Mar 7, 2025↗ | Patel Anish | CHIEF OPERATING OFFICER | Sell | 6,667 | $21.44 | $142.9K | 323,310 |
| Feb 27, 2025↗ | Hohl Benjamin | CHIEF FINANCIAL OFFICER | Sell | 3,250 | $20.41 | $66.3K | 13,000 |
| Feb 6, 2025↗ | Patel Anish | CHIEF OPERATING OFFICER | Sell | 6,667 | $21.93 | $146.2K | 329,977 |
| Feb 5, 2025↗ | Hohl Benjamin | CHIEF FINANCIAL OFFICER | Sell | 1,000 | $22.52 | $22.5K | 13,000 |
| Jan 27, 2025↗ | Hohl Benjamin | CHIEF FINANCIAL OFFICER | Sell | 3,250 | $21.59 | $70.2K | 13,000 |
| Jan 7, 2025↗ | Patel Anish | CHIEF OPERATING OFFICER | Sell | 28,367 | $24.18 | $685.9K | 336,734 |
| Dec 27, 2024↗ | Hohl Benjamin | CHIEF FINANCIAL OFFICER | Sell | 4,250 | $22.23 | $94.5K | 0 |
| Dec 13, 2024↗ | Hohl Benjamin | CHIEF FINANCIAL OFFICER | Sell | 1,000 | $25.04 | $25.0K | 13,000 |
| Nov 27, 2024↗ | Hohl Benjamin | CHIEF FINANCIAL OFFICER | Sell | 5,250 | $24.89 | $130.7K | 1,000 |
| Oct 28, 2024↗ | Hohl Benjamin | CHIEF FINANCIAL OFFICER | Sell | 6,250 | $28.56 | $178.5K | 650 |
| Oct 18, 2024↗ | Collins Helen Louise | CHIEF MEDICAL OFFICER | Sell | 816 | $30.00 | $24.5K | 0 |
| Oct 18, 2024↗ | Heyman Richard A. | Director | Sell | 1,570 | $30.00 | $47.1K | 123,673 |
| Oct 18, 2024↗ | Hohl Benjamin | CHIEF FINANCIAL OFFICER | Sell | 814 | $30.00 | $24.4K | 0 |
| Oct 18, 2024↗ | Kintz Samuel | PRESIDENT AND CEO | Sell | 924 | $30.00 | $27.7K | 1,002,890 |
| Oct 18, 2024↗ | Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Sell | 847 | $30.00 | $25.4K | 1,015,190 |
| Oct 18, 2024↗ | Patel Anish | CHIEF OPERATING OFFICER | Sell | 716 | $30.00 | $21.5K | 343,311 |
| Oct 15, 2024↗ | Heyman Richard A. | Director | Sell | 1,270 | $27.67 | $35.1K | 124,490 |
| Oct 8, 2024↗ | Ballal Rahul D. | Director | Sell | 10,420 | $28.17 | $293.6K | 22,341 |
| Oct 8, 2024↗ | Kintz Samuel | PRESIDENT AND CEO | Sell | 29,977 | $28.07 | $841.3K | 1,020,630 |
| Oct 8, 2024↗ | Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Sell | 51,145 | $28.11 | $1.44M | 1,054,010 |
| Oct 4, 2024↗ | Heyman Richard A. | Director | Sell | 2,825 | $27.51 | $77.7K | 125,760 |
| Oct 4, 2024↗ | Hohl Benjamin | CHIEF FINANCIAL OFFICER | Sell | 11,488 | $27.51 | $316.0K | 0 |
| Oct 4, 2024↗ | Kintz Samuel | PRESIDENT AND CEO | Sell | 14,936 | $27.51 | $410.9K | 1,036,520 |
| Oct 4, 2024↗ | Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Sell | 10,229 | $27.54 | $281.7K | 1,069,890 |
| Oct 1, 2024↗ | Heyman Richard A. | Director | Sell | 518 | $27.54 | $14.3K | 128,585 |
| Oct 1, 2024↗ | Hohl Benjamin | CHIEF FINANCIAL OFFICER | Sell | 521 | $27.54 | $14.3K | 0 |
| Oct 1, 2024↗ | Kintz Samuel | PRESIDENT AND CEO | Sell | 526 | $27.54 | $14.5K | 1,048,730 |
| Oct 1, 2024↗ | Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Sell | 527 | $27.54 | $14.5K | 1,077,410 |
| Sep 27, 2024↗ | Hohl Benjamin | CHIEF FINANCIAL OFFICER | Sell | 6,250 | $24.61 | $153.8K | 0 |
| Sep 16, 2024↗ | Heyman Richard A. | Director | Sell | 1,270 | $22.41 | $28.5K | 129,103 |
| Aug 29, 2024↗ | Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Sell | 12,000 | $22.49 | $269.8K | 1,077,990 |
| Aug 27, 2024↗ | Hohl Benjamin | CHIEF FINANCIAL OFFICER | Sell | 4,250 | $22.54 | $95.8K | 0 |
| Aug 26, 2024↗ | Kintz Samuel | PRESIDENT AND CEO | Sell | 12,000 | $22.89 | $274.7K | 1,049,260 |
| Aug 15, 2024↗ | Heyman Richard A. | Director | Sell | 1,270 | $23.25 | $29.5K | 130,993 |
| Jul 31, 2024↗ | Heyman Richard A. | Director | Sell | 2,351 | $27.50 | $64.7K | 131,643 |
| Jul 31, 2024↗ | Hohl Benjamin | CHIEF FINANCIAL OFFICER | Sell | 991 | $27.53 | $27.3K | 0 |
| Jul 31, 2024↗ | Kintz Samuel | PRESIDENT AND CEO | Sell | 2,270 | $27.56 | $62.6K | 1,061,260 |
| Jul 31, 2024↗ | Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Sell | 3,099 | $27.56 | $85.4K | 1,089,940 |
| Jul 29, 2024↗ | Hohl Benjamin | CHIEF FINANCIAL OFFICER | Sell | 5,250 | $26.68 | $140.1K | 61 |
| Jul 29, 2024↗ | Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Sell | 12,000 | $26.70 | $320.4K | 1,093,240 |
| Jul 25, 2024↗ | Kintz Samuel | PRESIDENT AND CEO | Sell | 12,000 | $24.92 | $299.1K | 1,071,730 |
| Jul 15, 2024↗ | Heyman Richard A. | Director | Sell | 1,270 | $24.80 | $31.5K | 133,345 |
| Jul 12, 2024↗ | Hohl Benjamin | CHIEF FINANCIAL OFFICER | Sell | 3,000 | $25.07 | $75.2K | 0 |
| Jul 12, 2024↗ | Patel Anish | CHIEF OPERATING OFFICER | Sell | 50,000 | $25.06 | $1.25M | 376,552 |
| Jul 1, 2024↗ | Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Sell | 12,000 | $22.89 | $274.7K | 1,105,040 |
| Jun 27, 2024↗ | Hohl Benjamin | CHIEF FINANCIAL OFFICER | Sell | 4,250 | $22.57 | $95.9K | 2,970 |
| Jun 25, 2024↗ | Kintz Samuel | PRESIDENT AND CEO | Sell | 12,000 | $21.66 | $259.9K | 1,076,100 |
| Jun 17, 2024↗ | Heyman Richard A. | Director | Sell | 1,270 | $21.48 | $27.3K | 134,615 |
| Jun 6, 2024↗ | Patel Anish | CHIEF OPERATING OFFICER | Sell | 1,133 | $20.06 | $22.7K | 0 |
| May 29, 2024↗ | Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Sell | 12,000 | $21.73 | $260.8K | 2,123 |
| May 28, 2024↗ | Hohl Benjamin | CHIEF FINANCIAL OFFICER | Sell | 4,250 | $23.18 | $98.5K | 2,344 |
| May 28, 2024↗ | Kintz Samuel | PRESIDENT AND CEO | Sell | 12,000 | $23.18 | $278.2K | 5,319 |
| May 16, 2024↗ | Gupta Rishi | Director | Sell | 1,033,300 | $22.14 | $22.88M | 7,663,350 |
| May 16, 2024↗ | Heyman Richard A. | Director | Sell | 1,270 | $23.74 | $30.1K | 135,885 |
| May 14, 2024↗ | Patel Anish | CHIEF OPERATING OFFICER | Sell | 1,107 | $25.00 | $27.7K | 0 |
| May 9, 2024↗ | Patel Anish | CHIEF OPERATING OFFICER | Sell | 260 | $25.06 | $6.5K | 0 |
| May 6, 2024↗ | Patel Anish | CHIEF OPERATING OFFICER | Sell | 4,875 | $22.72 | $110.8K | 0 |
| May 3, 2024↗ | Hohl Benjamin | CHIEF FINANCIAL OFFICER | Sell | 1,000 | $22.50 | $22.5K | 0 |
| Apr 29, 2024↗ | Hohl Benjamin | CHIEF FINANCIAL OFFICER | Sell | 3,250 | $16.97 | $55.2K | 0 |
| Apr 29, 2024↗ | Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Sell | 12,000 | $17.92 | $215.0K | 1,013 |
| Apr 25, 2024↗ | Kintz Samuel | PRESIDENT AND CEO | Sell | 12,000 | $16.89 | $202.7K | 0 |
| Apr 11, 2024↗ | Collins Helen Louise | CHIEF MEDICAL OFFICER | Sell | 20,000 | $25.07 | $501.5K | 0 |
| Apr 11, 2024↗ | Heyman Richard A. | Director | Sell | 6,964 | $24.11 | $167.9K | 137,235 |
| Apr 11, 2024↗ | Hohl Benjamin | CHIEF FINANCIAL OFFICER | Sell | 14,000 | $24.72 | $346.1K | 10,223 |
| Apr 11, 2024↗ | Kintz Samuel | PRESIDENT AND CEO | Sell | 47,709 | $25.04 | $1.19M | 0 |
| Apr 11, 2024↗ | Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Sell | 30,000 | $25.04 | $751.3K | 0 |
| Apr 11, 2024↗ | Patel Anish | CHIEF OPERATING OFFICER | Sell | 17,500 | $25.03 | $438.1K | 0 |
| Apr 10, 2024↗ | Ballal Rahul D. | Director | Sell | 67,000 | $23.36 | $1.56M | 45,441 |
| Apr 8, 2024↗ | Patel Anish | CHIEF OPERATING OFFICER | Sell | 4,875 | $18.60 | $90.7K | 3,141 |
| Apr 4, 2024↗ | Ballal Rahul D. | Director | Sell | 3,485 | $19.15 | $66.7K | 22,341 |
| Apr 1, 2024↗ | Ballal Rahul D. | Director | Sell | 3,237 | $19.08 | $61.8K | 22,341 |
| Apr 1, 2024↗ | Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Sell | 12,000 | $18.60 | $223.1K | 9,648 |
| Mar 27, 2024↗ | Hohl Benjamin | CHIEF FINANCIAL OFFICER | Sell | 3,250 | $18.25 | $59.3K | 182 |
| Mar 25, 2024↗ | Kintz Samuel | PRESIDENT AND CEO | Sell | 12,000 | $17.56 | $210.7K | 4,671 |
| Mar 20, 2024↗ | Ballal Rahul D. | Director | Sell | 13,278 | $19.16 | $254.5K | 22,341 |
| Mar 19, 2024↗ | Heyman Richard A. | Director | Sell | 1,270 | $14.50 | $18.4K | 143,470 |
| Mar 6, 2024↗ | Patel Anish | CHIEF OPERATING OFFICER | Sell | 4,875 | $15.64 | $76.2K | 7,472 |
| Feb 29, 2024↗ | Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Sell | 12,000 | $16.42 | $197.0K | 1,805 |
| Feb 27, 2024↗ | Hohl Benjamin | CHIEF FINANCIAL OFFICER | Sell | 3,250 | $16.97 | $55.2K | 0 |
| Feb 26, 2024↗ | Kintz Samuel | PRESIDENT AND CEO | Sell | 12,000 | $16.89 | $202.7K | 4,376 |
| Feb 15, 2024↗ | Heyman Richard A. | Director | Sell | 1,270 | $17.42 | $22.1K | 144,740 |
| Feb 6, 2024↗ | Patel Anish | CHIEF OPERATING OFFICER | Sell | 4,875 | $15.11 | $73.7K | 12,347 |
| Jan 30, 2024↗ | Heyman Richard A. | Director | Sell | 1,270 | $16.41 | $20.8K | 146,010 |
| Jan 29, 2024↗ | Hohl Benjamin | CHIEF FINANCIAL OFFICER | Sell | 3,250 | $15.81 | $51.4K | 0 |
| Jan 29, 2024↗ | Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Sell | 12,000 | $15.85 | $190.3K | 0 |
| Jan 25, 2024↗ | Kintz Samuel | President and CEO | Sell | 12,000 | $15.69 | $188.2K | 9,458 |
| Jan 22, 2024↗ | Patel Anish | Chief Operating Officer | Sell | 4,875 | $15.13 | $73.8K | 17,222 |
| Dec 29, 2023↗ | Lyssikatos Joseph P | Chief Scientific Officer | Sell | 12,000 | $14.28 | $171.4K | 2,849 |
| Dec 28, 2023↗ | Hohl Benjamin | Chief Financial Officer | Sell | 11,870 | $15.02 | $178.3K | 0 |
| Dec 28, 2023↗ | Patel Anish | Chief Operating Officer | Sell | 13,540 | $15.02 | $203.3K | 33,117 |
| Dec 26, 2023↗ | Kintz Samuel | President and CEO | Sell | 12,000 | $14.64 | $175.7K | 0 |
| Dec 22, 2023↗ | Hohl Benjamin | Chief Financial Officer | Sell | 1,130 | $15.07 | $17.0K | 0 |
| Dec 22, 2023↗ | Patel Anish | Chief Operating Officer | Sell | 1,085 | $15.03 | $16.3K | 35,739 |
| Dec 21, 2023↗ | Heyman Richard A. | Director | Sell | 216 | $13.00 | $2.8K | 147,448 |
| Dec 21, 2023↗ | Kintz Samuel | President and CEO | Sell | 8,195 | $13.05 | $106.9K | 0 |
| Dec 21, 2023↗ | Lyssikatos Joseph P | Chief Scientific Officer | Sell | 6,566 | $13.07 | $85.8K | 0 |
| Dec 20, 2023↗ | Kintz Samuel | President and CEO | Sell | 7,779 | $13.01 | $101.2K | 0 |
| Dec 19, 2023↗ | Heyman Richard A. | Director | Sell | 4,280 | $13.02 | $55.7K | 149,565 |
| Dec 19, 2023↗ | Lyssikatos Joseph P | Chief Scientific Officer | Sell | 8,888 | $13.01 | $115.6K | 0 |
| Nov 3, 2023↗ | Kintz Samuel | President and CEO | Sell | 8,026 | $13.08 | $105.0K | 0 |
| Nov 3, 2023↗ | Lyssikatos Joseph P | Chief Scientific Officer | Sell | 8,546 | $13.08 | $111.8K | 0 |
| Sep 29, 2023↗ | Lyssikatos Joseph P | Chief Scientific Officer | Sell | 12,000 | $13.62 | $163.5K | 0 |
| Sep 25, 2023↗ | Kintz Samuel | President and CEO | Sell | 12,000 | $13.81 | $165.7K | 0 |
| Feb 22, 2023↗ | Ballal Rahul D. | Chief Executive Officer | Sell | 32,861 | $4.66 | $153.1K | 87,835 |
| Feb 22, 2023↗ | GRAY MICHAEL | CFO & COO | Sell | 9,856 | $4.67 | $46.0K | 27,610 |
| Jan 30, 2023↗ | Ballal Rahul D. | Chief Executive Officer | Sell | 11,313 | $3.91 | $44.2K | 120,696 |
| Jan 30, 2023↗ | GRAY MICHAEL | CFO & COO | Sell | 3,596 | $3.92 | $14.1K | 37,466 |
| Jan 3, 2023↗ | Leonard Braden Michael | 10% Owner | Sell | 1,250,000 | $4.00 | $5.00M | 1,767,770 |
| Dec 30, 2022↗ | Leonard Braden Michael | 10% Owner | Sell | 20,000 | $4.04 | $80.8K | 230,000 |
| Dec 28, 2022↗ | Leonard Braden Michael | 10% Owner | Sell | 20,000 | $4.04 | $80.8K | 269,843 |
| Dec 22, 2022↗ | Leonard Braden Michael | 10% Owner | Sell | 50,000 | $4.06 | $203.0K | 318,922 |
ELVN Insiders
Similar Stocks to ELVN
VRTX
Vertex Pharmaceuticals Incorporated
$470.20-1.66%
$121.44B
REGN
Regeneron Pharmaceuticals, Inc.
$743.51-0.41%
$77.57B
ALNY
Alnylam Pharmaceuticals, Inc.
$313.45-1.19%
$42.07B
INSM
Insmed Incorporated
$139.06-0.33%
$30.07B
UTHR
United Therapeutics Corporation
$536.12+0.97%
$23.50B
MRNA
Moderna, Inc.
$52.56-1.89%
$20.76B
ROIV
Roivant Sciences Ltd.
$28.06-1.44%
$20.08B
RPRX
Royalty Pharma plc
$45.65-0.57%
$19.56B